Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell … – Business Wire (press release)

Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell ...Business Wire (press release)NEW YORK--(BUSINESS WIRE)--Angiocrine Bioscience, Inc. announced today that it has licensed the rights to a new technology developed by a team of...
http://blog.zandcell.com/angiocrine-bioscience-licenses-new-stem-cell-technology-from-weill-cornell-business-wire-press-release/?utm_source=rss&utm_medium=rss&utm_campaign=angiocrine-bioscience-licenses-new-stem-cell-technology-from-weill-cornell-business-wire-press-release